Takeshi Ujike

2.1k total citations
74 papers, 1.1k citations indexed

About

Takeshi Ujike is a scholar working on Pulmonary and Respiratory Medicine, Surgery and Oncology. According to data from OpenAlex, Takeshi Ujike has authored 74 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 39 papers in Pulmonary and Respiratory Medicine, 28 papers in Surgery and 24 papers in Oncology. Recurrent topics in Takeshi Ujike's work include Renal cell carcinoma treatment (20 papers), Bladder and Urothelial Cancer Treatments (14 papers) and Prostate Cancer Treatment and Research (13 papers). Takeshi Ujike is often cited by papers focused on Renal cell carcinoma treatment (20 papers), Bladder and Urothelial Cancer Treatments (14 papers) and Prostate Cancer Treatment and Research (13 papers). Takeshi Ujike collaborates with scholars based in Japan, United States and Germany. Takeshi Ujike's co-authors include Motohide Uemura, Atsunari Kawashima, Norio Nonomura, Kazutoshi Fujita, Akira Nagahara, Kyosuke Matsuzaki, Yasushi Miyagawa, Taigo Kato, Koji Hatano and Yujiro Hayashi and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Takeshi Ujike

72 papers receiving 1.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Takeshi Ujike Japan 19 454 437 313 285 270 74 1.1k
Akira Nagahara Japan 22 546 1.2× 547 1.3× 344 1.1× 252 0.9× 400 1.5× 75 1.3k
Sadafumi Kawamura Japan 19 292 0.6× 529 1.2× 152 0.5× 144 0.5× 143 0.5× 68 887
Atsunari Kawashima Japan 25 734 1.6× 724 1.7× 471 1.5× 472 1.7× 744 2.8× 116 1.9k
Malcolm Crundwell United Kingdom 15 521 1.1× 514 1.2× 245 0.8× 875 3.1× 328 1.2× 28 1.6k
Yukiharu Todo Japan 30 547 1.2× 251 0.6× 491 1.6× 609 2.1× 473 1.8× 102 3.1k
Christina H. Son United States 11 167 0.4× 269 0.6× 195 0.6× 194 0.7× 291 1.1× 35 888
Anders Ullén Sweden 18 398 0.9× 386 0.9× 195 0.6× 646 2.3× 449 1.7× 88 1.3k
Debasish Sundi United States 21 180 0.4× 966 2.2× 201 0.6× 453 1.6× 444 1.6× 60 1.4k
Javier Puente Spain 18 424 0.9× 639 1.5× 426 1.4× 320 1.1× 786 2.9× 164 1.5k
Jordi Xercavins Spain 26 442 1.0× 151 0.3× 487 1.6× 364 1.3× 490 1.8× 86 1.9k

Countries citing papers authored by Takeshi Ujike

Since Specialization
Citations

This map shows the geographic impact of Takeshi Ujike's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Takeshi Ujike with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Takeshi Ujike more than expected).

Fields of papers citing papers by Takeshi Ujike

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Takeshi Ujike. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Takeshi Ujike. The network helps show where Takeshi Ujike may publish in the future.

Co-authorship network of co-authors of Takeshi Ujike

This figure shows the co-authorship network connecting the top 25 collaborators of Takeshi Ujike. A scholar is included among the top collaborators of Takeshi Ujike based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Takeshi Ujike. Takeshi Ujike is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Yamamichi, Gaku, Taigo Kato, Noriaki Arakawa, et al.. (2024). GDF15 propeptide promotes bone metastasis of castration-resistant prostate cancer by augmenting the bone microenvironment. Biomarker Research. 12(1). 147–147. 3 indexed citations
2.
Kato, Taigo, Akira Nagahara, Atsunari Kawashima, et al.. (2021). Therapeutic and Clinical Outcomes of Robot-assisted Partial NephrectomyVersusCryoablation for T1 Renal Cell Carcinoma. In Vivo. 35(3). 1573–1579. 16 indexed citations
3.
Matsuzaki, Kyosuke, Kazutoshi Fujita, Eisuke Tomiyama, et al.. (2021). MiR-30b-3p and miR-126-3p of urinary extracellular vesicles could be new biomarkers for prostate cancer. Translational Andrology and Urology. 10(4). 1918–1927. 34 indexed citations
4.
Kato, Taigo, Akira Nagahara, Norihiko Kawamura, et al.. (2021). Real-world Outcomes of Tyrosine Kinase Inhibitors Immediately After Immune Checkpoint Inhibitors in Renal Cell Carcinoma. Anticancer Research. 41(11). 5811–5816. 5 indexed citations
5.
Koh, Yoko, Atsunari Kawashima, Takeshi Ujike, et al.. (2020). Failure to achieve castrate level of serum testosterone during luteinizing hormone-releasing hormone agonist therapy in a patient with prostate cancer. Anti-Cancer Drugs. 31(10). 1099–1102. 1 indexed citations
6.
Fujita, Kazutoshi, Taigo Kato, Koji Hatano, et al.. (2020). Intratumoral and s.c. injection of inactivated hemagglutinating virus of Japan envelope (GEN0101) in metastatic castration‐resistant prostate cancer. Cancer Science. 111(5). 1692–1698. 15 indexed citations
7.
Kato, Taigo, Eisuke Tomiyama, Yoko Koh, et al.. (2020). A Potential Mechanism of Anticancer Immune Response Coincident With Immune-related Adverse Events in Patients With Renal Cell Carcinoma. Anticancer Research. 40(9). 4875–4883. 9 indexed citations
8.
Nakamaru, Ryo, Kōichi Yamamoto, Satoko Nozato, et al.. (2019). A case of primary aldosteronism with resistant hypertension successfully treated by unilateral adrenalectomy after unsuccessful classification of subtype in adrenal venous sampling. SHILAP Revista de lepidopterología. 7(10). 1895–1899. 2 indexed citations
9.
Koh, Yoko, Takeshi Ujike, Kazutoshi Fujita, et al.. (2019). [A Case of Urethral Carcinoma in Situ Resected by Urethrectomy of Anterior Urethra].. PubMed. 65(8). 337–340. 1 indexed citations
10.
Fujita, Kazutoshi, Yasutomo Nakai, Taigo Kato, et al.. (2019). Intratumoral and subcutaneous injection of HVJ-E (GEN0101) for metastatic castration-resistant prostate cancer: Open-label, phase I, dose escalation study.. Journal of Clinical Oncology. 37(15_suppl). e16511–e16511. 1 indexed citations
11.
Matsuzaki, Kyosuke, Kazutoshi Fujita, Yujiro Hayashi, et al.. (2018). STAT3 expression is a prognostic marker in upper urinary tract urothelial carcinoma. PLoS ONE. 13(8). e0201256–e0201256. 8 indexed citations
12.
Fujita, Kazutoshi, Yasutomo Nakai, Atsunari Kawashima, et al.. (2017). Phase I/II clinical trial to assess safety and efficacy of intratumoral and subcutaneous injection of HVJ-E in castration-resistant prostate cancer patients. Cancer Gene Therapy. 24(7). 277–281. 17 indexed citations
13.
Fujita, Kazutoshi, Hideaki Kume, Kyosuke Matsuzaki, et al.. (2017). Proteomic analysis of urinary extracellular vesicles from high Gleason score prostate cancer. Scientific Reports. 7(1). 42961–42961. 144 indexed citations
14.
15.
Fujita, Kazutoshi, Takeshi Ujike, Akira Nagahara, et al.. (2015). Endoglin expression in upper urinary tract urothelial carcinoma is associated with intravesical recurrence after radical nephroureterectomy. International Journal of Urology. 22(5). 463–467. 7 indexed citations
16.
Nagahara, Akira, Motohide Uemura, Atsunari Kawashima, et al.. (2015). R.E.N.A.L. nephrometry score predicts postoperative recurrence of localized renal cell carcinoma treated by radical nephrectomy. International Journal of Clinical Oncology. 21(2). 367–372. 15 indexed citations
17.
Matsushita, Makoto, et al.. (2013). [A case report of renal pelvic tumor in horseshoe kidney].. PubMed. 59(8). 523–6. 1 indexed citations
18.
Kawashima, Atsunari, et al.. (2009). PLASMACYTOID UROTHELIAL CARCINOMA OF THE BLADDER: A CASE REPORT. The Japanese Journal of Urology. 100(5). 590–594. 6 indexed citations
19.
Fujita, Kazutoshi, Masashi Nakayama, Yasutomo Nakai, et al.. (2009). Vascular endothelial growth factor receptor 1 expression in pelvic lymph nodes predicts the risk of cancer progression after radical prostatectomy. Cancer Science. 100(6). 1047–1050. 12 indexed citations
20.
Yoshida, Takahiro, et al.. (2007). [Parastomal hernia with incarcerated necrosis at ascending colon 18 years after the construction of ileal conduit: a case report].. PubMed. 53(3). 187–9.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Akira Nagahara Breakdown of academic impact, for papers by Sadafumi Kawamura Breakdown of academic impact, for papers by Atsunari Kawashima Breakdown of academic impact, for papers by Malcolm Crundwell Breakdown of academic impact, for papers by Yukiharu Todo Breakdown of academic impact, for papers by Christina H. Son Breakdown of academic impact, for papers by Anders Ullén Breakdown of academic impact, for papers by Debasish Sundi Breakdown of academic impact, for papers by Javier Puente Breakdown of academic impact, for papers by Jordi Xercavins
Rankless by CCL
2026